Contact
searchSearch
HMP Global

Volume 18 - Issue 5 - May, 2006

Feature

Clinical Images
Disruption of In-Stent Neointima Causing Acute Mycoardial Infarction
08/01/2008
Matthew I. Worthley, MBBS, PhD; Ian T. Meredith, BSc, PhD, MBBS, FRACP, MD; Stephen G. Worthley, MBBS, PhD, MD, PhDH, MB, BS 
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old...
08/01/2008
Journal of Invasive Cardiology
Review
Routine Pressure-Derived Fractional Flow Reserve Guidance: From Diagnostic to Everyday Practice
08/01/2008
William K. Hau, PhD
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the...
08/01/2008
Journal of Invasive Cardiology
Review
Routine Pressure-Derived Fractional Flow Reserve Guidance:
From Diagnostic to Everyday Practice
08/01/2008
William K. Hau, PhD
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the most widely used means of assessing the severity of coronary stenosis. Despite its universal acceptance, coronary angiography is simply luminography, and is inherently limited in determining the physiological...
Coronary angiography remains the...
08/01/2008
Journal of Invasive Cardiology
Clinical Images
Disruption of In-Stent Neointima Causing Acute Mycoardial Infarction
08/01/2008
Stephen G. Worthley, MBBS, PhD, MD, PhDH, MB, BS ; Matthew I. Worthley, MBBS, PhD; Ian T. Meredith, BSc, PhD, MBBS, FRACP, MD
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old male presented with an acute anterior myocardial infarction and was referred for immediate primary percutaneous coronary intervention. His cardiovascular risk factors included smoking, hypercholesterolemia,...
Case Presentation. A 25-year-old...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Initial Experience with a Novel Coronary Rinsing and Thrombectomy System: “Rinspiration”
08/01/2008
Bruce McManus, MD; Gordon E. Pate, MB; John G. Webb, MD; G.B. John Mancini, MD; Mitchell W. Krucoff, MD; Mann Chandavimol, MD; Jaap N. Hamburger, MD
Percutaneous coronary intervention (PCI) plays a prominent role in the management of acute myocardial infarction (MI). However intracoronary thrombus often contributes to suboptimal angiographic results, morbidity and mortality.1 Approaches...
Percutaneous coronary intervention (PCI) plays a prominent role in the management of acute myocardial infarction (MI). However intracoronary thrombus often contributes to suboptimal angiographic results, morbidity and mortality.1 Approaches...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Evaluation of a New Polymer-Coated Paclitaxel-Eluting Stent
for Treatment of De Novo Lesions: Six-Month Clinical and Angiograph
08/01/2008
Ulrich Gerckens, MD; Victor Lim, MD; Ralf Mueller, MD; Thomas Schmidt, MD; Lutz Buellesfeld, MD; Eberhard Grube, MD
In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...
In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...
In-stent restenosis as a result...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Angioscopically-Determined Extent of Coronary Atherosclerosis Is Associated with Severity of Acute Coronary Syndrome
08/01/2008
Yasunori Ueda, MD, PhD; Jota Oyabu, MD; Katsuki Okada, MD; Tomokazu Murakawa, MD; Atsushi Hirayama, MD, PhD; Kazuhisa Kodama, MD, PhD
Acute myocardial infarction and unstable angina pectoris have been reported pathologically and angioscopically to share the common pathophysiology of plaque disruption with thrombosis. Both are classified as acute coronary syndromes (ACS)....
Acute myocardial infarction and unstable angina pectoris have been reported pathologically and angioscopically to share the common pathophysiology of plaque disruption with thrombosis. Both are classified as acute coronary syndromes (ACS)....
Acute myocardial infarction and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
Comparison Between Sirolimus- and Paclitaxel-Eluting Stents
for the Treatment of Chronic Total Occlusions
08/01/2008
Seong-Wook Park, MD, PhD; Seung-Jung Park, MD, PhD; Myeong-Ki Hong, MD; Young-Hak Kim, MD; Jae Sik Jang, MD, PhD; Cheol-Whan Lee, MD, PhD; Bong-Ki Lee; Ki-Hoon Han, MD, PhD; Duk-Woo Park, MD; Jae-Joong Kim, MD, PhD
Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions has a lower success rate and is technically demanding despite advances in equipment and operator experience.1–3 Although several studies showed favorable...
Percutaneous coronary intervention (PCI) of chronic total occlusion (CTO) lesions has a lower success rate and is technically demanding despite advances in equipment and operator experience.1–3 Although several studies showed favorable...
Percutaneous coronary...
08/01/2008
Journal of Invasive Cardiology
A Case of Hypertrophic Obstructive Cardiomyopathy Complicated by a Single Coronary Artery Treated by Transcoronary Septal Ablati
08/01/2008
Kazuyuki Ishii, MD; Hidehiko Hara, MD; Masato Nakamura, MD
Hypertrophic obstructive cardiomyopathy (HOCM) is a disease characterized by left ventricular hypertrophy and the presence of an outflow tract gradient. Transcoronary ablation of the septal hypertrophy (TASH) by selective transcatheter septal...
Hypertrophic obstructive cardiomyopathy (HOCM) is a disease characterized by left ventricular hypertrophy and the presence of an outflow tract gradient. Transcoronary ablation of the septal hypertrophy (TASH) by selective transcatheter septal...
Hypertrophic obstructive...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Sirolimus or Paclitaxel Drug-Eluting Stents for Treatment of Chronic Total Occlusions of Coronary Arteries: Much Ado about Very
08/01/2008
Phil Hemstreet, MD; H. Vernon Anderson, MD
Chronic total occlusions (CTO) represent about 10% of all coronary lesions treated by percutaneous interventions. They traditionally have posed significant problems for patients and operators, with both lower initial success rates and higher...
Chronic total occlusions (CTO) represent about 10% of all coronary lesions treated by percutaneous interventions. They traditionally have posed significant problems for patients and operators, with both lower initial success rates and higher...
Chronic total occlusions (CTO)...
08/01/2008
Journal of Invasive Cardiology

News

Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest
CardiAMP Procedure
Cell Therapy
BioCardia Phase 3 CARDIAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
03/31/2025
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF Trial, patients who received the novel cell therapy adjunctive to medication experienced decreased mortality and MACCE, with improved quality of life, when compared to those on medication alone," said...
"In this rigorous CardiAMP-HF...
03/31/2025
Cath Lab Digest
Peripheral Arterial Disease
New Study Finds Peripheral Artery Disease Often Underdiagnosed and Undertreated; Opportunity to Improve Treatments and Lower Death Rates
03/31/2025
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522 patients who had a symptomatic peripheral artery disease diagnosis at Intermountain Health facilities between January 2006 and December 2021 and were seen once in follow-up within at least 18 months of their...
Researchers identified 7,522...
03/31/2025
Cath Lab Digest
TAVR
Evolut Low Risk Trial: Medtronic Evolut TAVR System Shows Durable Clinical Outcomes and Outstanding Valve Performance at 5 Years in Low-Risk AS Patients
03/31/2025
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, MD.
"Results at five years support...
03/31/2025
Cath Lab Digest
Calcium Score
Low Coronary Artery Calcium Score is Associated with An Excellent Prognosis Regardless of a Person’s Age, New Intermountain Health Study Finds
03/31/2025
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque burden is not only highly prognostic of good heart health at any age, but also of excellent overall survival,” said Jeffrey L. Anderson, MD, principal investigator of the study.
“We found that a zero-plaque...
03/31/2025
Cath Lab Digest

CRT Conference Coverage
Disparities in Interventional Cardiology
04/02/2025
Laura Simson
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon "Disparities in Interventional Cardiology" session at CRT 2025, experts presented compelling data and discussed the barriers that limit diverse representation in the field, ranging from clinical trials and...
At the Sunday afternoon...
04/02/2025
Journal of Invasive Cardiology
CRT Conference Coverage
Artificial Intelligence in Coronary Artery Disease Diagnosis and Intervention
04/02/2025
Laura Simson
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session and ensuing panel discussion at CRT 2025, Dr Ran Kornowski of the Rabin Medical Center in Petach-Tikva, Israel, detailed how AI is transforming clinical practice and research in interventional cardiology.
In his Sunday morning session...
04/02/2025
Journal of Invasive Cardiology
Original Contribution
Polidocanol Ablation in Midventricular Obstructive Cardiomyopathy: Novel Approach and Early Outcomes
04/01/2025
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding polidocanol use for septal ablation, particularly in the context of midventricular obstruction (MVO) . This study presents the first reported use of polidocanol for septal ablation in patients with MVO.
Limited data exist regarding...
04/01/2025
Journal of Invasive Cardiology
Original Contribution
Heart Rate Variability of Interventional Cardiology Fellows and Attendings and Changes Over Time
04/01/2025
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress levels of interventional cardiology (IC) fellows and attendings using both objective (heart rate variability) and subjective (State Trait Anxiety Inventory) metrics across the IC fellowship.
The study examined the stress...
04/01/2025
Journal of Invasive Cardiology
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

May 2006 Volume 18 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use